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Abstract
Initial steps in establishing an optimal strategy for functional bioengineered tissues is generation of three-dimensional
constructs containing cells with the appropriate organization and phenotype. To effectively utilize rhesus monkey
decellularized kidney scaffolds, these studies evaluated two key parameters: (1) residual scaffold components after
decellularization including proteomics analysis, and (2) the use of undifferentiated human embryonic stem cells (hESCs) for
recellularization in order to explore cellular differentiation in a tissue-specific manner. Sections of kidney and lung were
selected for a comparative evaluation because of their similar pattern of organogenesis. Proteomics analysis revealed the
presence of growth factors and antimicrobial proteins as well as stress proteins and complement components.
Immunohistochemistry of recellularized kidney scaffolds showed the generation of Cytokeratin+ epithelial tubule
phenotypes throughout the scaffold that demonstrated a statistically significant increase in expression of kidney-associated
genes compared to baseline hESC gene expression. Recellularization of lung scaffolds showed that cells lined the alveolar
spaces and demonstrated statistically significant upregulation of key lung-associated genes. However, overall expression of
kidney and lung-associated markers was not statistically different when the kidney and lung recellularized scaffolds were
compared. These results suggest that decellularized scaffolds have an intrinsic spatial ability to influence hESC
differentiation by physically shaping cells into tissue-appropriate structures and phenotypes, and that additional
approaches may be needed to ensure consistent recellularization throughout the matrix.
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Introduction
There is an ongoing interest in using native extracellular matrix
(ECM) scaffolds derived from decellularized tissues as a potential
method for repair of organs damaged by disease. Although results
are promising, the clinical outcome of recent studies, such as those
involving transplantation of tissue engineered decellularized
airways, present issues such as the biomechanical collapse of the
graft [1–3]. These findings indicate a more exhaustive in vitro
understanding of the components of decellularized tissues is
required before translational applications can be fully realized and
achieved. For example, there is a need to explore fundamental
questions related to scaffold properties including the contents that
remain after the decellularization process and the tissue-specific
properties that may potentiate lineage specification during
recellularization. Differences in ECM composition, morphology,
and structural properties are also known to impact scaffold
physical properties and biological outcomes [4–6]. ECM proteins
provide physical biomechanical structure and interactive ligand-
mediated feedback to guide and alter the fate of cells. These
features must be carefully considered in order to better understand
and effectively utilize the native ECM architecture provided by
decellularized scaffolds for tissue repair.
Studies by our group have demonstrated that rhesus monkey
kidneys of all age groups (fetal to adult) can be decellularized to
provide a natural ECM with preserved structural and biological
properties [7]. These scaffolds were shown to support migration of
renal cells from kidney explants in an age-dependent manner, and
elongation of tubules that was enhanced with the addition of
cytokines [8]. The first goal of the studies described herein was to
characterize the residual contents of kidney and lung scaffolds
including DNA/RNA, Major Histocompatibility Complex (MHC)
antigens, cellular markers, growth factors, and proteins. Kidney
and lung were selected for a comparative evaluation because of
their similar pattern of organogenesis, which is driven by
reciprocal mesenchymal-to-epithelial interactions that lead to
branching morphogenesis. The second goal was to determine
the tissue specificity of the scaffolds by comparing recellularization
efficiency using human embryonic stem cells (hESCs). Thus, two
central issues were explored: detection of the residual components
remaining in decellularized tissue scaffolds which could impact the
recellularization process and ultimately transplantation, and if
decellularized kidney and lung scaffolds exhibit tissue-specific
properties and the ability to drive hESC differentiation in a tissue
specific manner.
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Materials and Methods
Ethics Statement and Tissue Collection
All animal protocols were approved prior to implementation by
the Institutional Animal Care and Use Committee (IACUC) at the
University of California, Davis, and all procedures conformed to
the requirements of the Animal Welfare Act. Activities related to
animal care including housing, feeding, and environmental
enrichment were performed in accordance with IACUC-approved
standard operating procedures (SOPs) at the California National
Primate Research Center (http://www.cnprc.ucdavis.edu). Eutha-
nasia was consistent with the recommendations of the American
Veterinary Medical Association (AVMA) Guidelines on Euthana-
sia and Primate Center SOPs (overdose of pentobarbital). Tissue
collection was performed using established methods and included
juvenile (1–3 years) kidneys (transverse sections) (N=3) and caudal
lung lobes (sagittal sections) (N=3) from rhesus monkeys (Macaca
mulatta) as previously described [7]. All tissues were placed in
Roswell Park Memorial Institute medium (RPMI, Life Technol-
ogies, Grand Island, NY) upon collection with processing
conducted at the time of tissue harvest.
Decellularization
Decellularization of tissue sections was performed using
established protocols [8]. Briefly, kidney transverse sections were
washed with phosphate buffered saline (PBS, Life Technologies)
followed by a decellularization solution of 1% (v/v) sodium
dodecyl sulfate (SDS, Life Technologies) or 0.1% (v/v) for lung
sections diluted in UltraPureTM sterile distilled water (Life
Technologies) at 4uC. Lung decellularization was optimized with
detergents Triton X-100 and SDS and with three detergent
concentrations 0.01%, 0.1%, and 1% v/v all carried out at 4uC.
The solution was changed 8 h after initial tissue harvest and then
every 48 h until the tissue was transparent (approximately 10–14
days for kidney sections and 20–24 days for lung sections).
Decellularized scaffolds were gently washed with PBS and stored
in 1% (v/v) penicillin-streptomycin (pen-strep, Life Technologies)
in PBS at 4uC until use (0–2 months maximum).
Proteomics
Protein-works Protein Profiling service with 40 fractions per
sample was performed by MS Bioworks LLC (Ann Arbor, MI) on
one decellularized kidney scaffold biopsy and one lung scaffold
biopsy. The punch biopsy was collected from a transverse kidney
section or sagittal caudal lung lobe section using a sterile 8 mm
hollow BiopunchH (Healthlink, Jacksonville, FL). Samples were
extracted by mechanical tissue disruption in a Bullet Blender (Next
Advance, Averill Park, NY) in 50 mM Tris-HCl, pH 8.0, 150 mM
NaCl, 0.1% SDS, 0.05% ProteaseMax (Promega, Madison, WI),
1X Complete Protease Inhibitor (Roche, Pleasanton, CA), and 1X
PhoStop phosphatase inhibitor (Roche). Cell debris was pelleted
via centrifugation and the supernatant was quantified using a
Qubit fluorometer (Life Technologies). Each sample (20 mg) was
loaded onto a 4–12% SDS-PAGE gel (Novex, Life Technologies).
The gel was excised into 40 segments per lane and gel slices were
processed using a robot (ProGest, DigiLab, Holliston, MA) for the
following processing cycle: 25 mM ammonium bicarbonate wash,
acetonitrile wash reduction with 10 mM dithiothreitol at 60uC,
alkylation with 50 mM iodoacetamide at room temperature,
digestion with trypsin (Promega) at 37uC for 4 h, and quenching
with formic acid. The supernatant was analyzed directly without
further processing.
Each gel digest was analyzed by nano liquid chromatography
and tandem mass spectrometry (LC/MS/MS) with a Waters
NanoAcquity HPLC system interfaced to a ThermoFisher Orbi-
trap Velos Pro Peptides (Thermo Fisher Scientific, Waltham, MA)
and were loaded on a trapping column and eluted over a 75 mm
analytical column at 350 nL/min; both columns were packed with
Jupiter Proteo resin (Phenomenex, Torrance, CA). The mass
spectrometer was operated in data-dependent mode, with MS
performed in the Orbitrap at 60,000 full width at half maximum
(FWHM) resolution and MS/MS performed in the linear trap
quadrupole (LTQ). The 15 most abundant ions were selected for
MS/MS.
Data were searched using a local copy of Mascot with the
following parameters: Enzyme: Trypsin; Database 1: Uniprot M.
mulatta (concatenated forward and reverse plus common contam-
inants); Database 2: NCBI M. mulatta (concatenated forward and
reverse plus common contaminants); Fixed modification: Carba-
midomethyl (C); Variable modifications: Oxidation (M), Acetyl
(Protein N-term), Deamidation (NQ), Pyro-Glu (N-term Q); Mass
values: Monoisotopic; Peptide Mass Tolerance: 10 ppm; Fragment
Mass Tolerance: 0.8 Da; Max Missed Cleavages: 2.
Mascot DAT files were parsed into Scaffold software (Proteome
Software, Inc., Portland, OR) for validation, filtering, and to
create a non-redundant list per sample. Data were filtered using a
minimum protein value of 90%, a minimum peptide value of 50%
(Prophet scores), and requiring at least two unique peptides per
protein.
Data were searched against both NCBI M. mulatta and Uniprot
M. mulatta databases. Peptides belonging to a given protein were
normalized to the corresponding molecular weight. The abun-
dance of each protein in the scaffold was assessed based on the
percentage each occupied of the total normalized peptide spectra.
Recellularization with hESCs
Prior to recellularization, scaffolds were washed overnight in
sterile filtered (0.22 mm pore size, Millipore, Billerica, MA) 70%
(v/v) ethanol in super-Q water at room temperature on a Dynal
tube rotator (Dynal, Inc., New Hyde Park, NY) at 25 revolutions/
min and rehydrated with several 24 h washes of PBS with 1% pen-
strep.
hESCs (WA09 [H9]; NIH number 0062; passage 36) were
cultured on irradiated mouse embryonic feeders and expanded
from an established bank that was characterized as described
previously for pluripotency markers and shown to spontaneously
differentiate via embryoid bodies towards ectoderm, endoderm,
and mesoderm [9]. Samples of undifferentiated cells (Day 0) were
obtained for quantitative PCR (qPCR) and stored in RNeasy Lysis
Buffer (Buffer RLT, Qiagen, Valencia, CA) with 1% 2-Mercap-
toethanol at #-20uC until processed. Samples were also collected
in PBS (16106 cells) to develop a standard curve to equate e-globin
(housekeeping gene) copy number with cell numbers. Juvenile
kidney (N= 3) and lung (N=3) scaffolds were cut into cylindrical
biopsies (8 mm diameter) and seeded with approximately 56105
undifferentiated hESCs on Day 0. Non-seeded decellularized
kidney and lung scaffolds were also collected on Day 0 for
histological analysis. Each seeded scaffold was suspended on PET
track-etched membrane cell culture inserts (1 cm diameter,
1.0 mm pore size, BD Biosciences, San Jose, CA). Once seeded,
all scaffolds were cultured in Dulbecco’s Modified Eagle’s Medium
high glucose with 10% fetal bovine serum (FBS), 1% pen-strep,
and 1% L-glutamine at 37uC and 5% CO2. Two days after cells
were seeded onto the scaffolds, each scaffold was gently transferred
to new culture inserts to quantify non-adherent cells remaining in
the original inserts with a hemacytometer and viability assessed
with trypan blue. A reference Day 2 scaffold was collected from
each group and stored at 4uC in 1 ml RNAlaterH stabilization
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solution (Ambion, Foster City, CA) for 48 h and then at #-80uC
until processed for qPCR. On Day 8 scaffolds were collected for
morphological analysis by fixing in 10% phosphate buffered
formalin (Thermo Fisher Scientific, Waltham, MA) and embedded
in paraffin or collected for qPCR (stored at 4uC in 1 ml RNAlaterH
for 48 h and then at #-80uC until processed) (Figure 1).
Approximately 56105 hESCs were seeded onto MatrigelTM
(BD Biosciences; in a 50:50 dilution of MatrigelTM to medium) or
were cultured in low adhesion plates to form embryoid bodies.
MatrigelTM controls were allowed to form a semi-solid gel in the
culture inserts to serve as three-dimensional (3D) ECM controls.
MatrigelTM and embryoid body control samples (N= 3) were
collected on day 8 of culture for immunohistochemistry (IHC) by
dissolving MatrigelTM with cold PBS, followed by centrifugation at
1,500 revolutions per min (rpm) for 5 min at 4uC. Cell pellets for
IHC were gently fixed in 10% formalin for 48 h and embedded in
paraffin.
hESCs were cultured in medium for embryoid body formation
with solutions of 0%, 0.0001%, 0.001%, 0.01%, or 0.1% SDS (v/
v) in low-adhesion plates for 8 days, with medium changes every
48 h. At the end of the culture period embryoid bodies were
collected, washed with PBS, and centrifuged at 1,500 rpm for
5 min to form a pellet. Pellets were fixed in 10% formalin for 48 h
and embedded in paraffin for IHC.
To assess the effects of soluble molecules released from empty
scaffolds on cell surfactant protein expression, empty decellular-
ized juvenile kidney scaffolds (N= 3) were incubated with medium
for 8 days. Every 24 h, the incubated medium was transferred
from the empty scaffold culture to low adhesion plates containing
hESCs for embryoid body formation. After 8 days, scaffolds and
pellets were collected and fixed in 10% formalin for 48 h and
embedded in paraffin for IHC.
Morphology
Morphology and scaffold recellularization were assessed by
serial sectioning (5–6 mm) of the entire recellularized paraffin-
embedded scaffold. Hematoxylin and Eosin (H&E) staining and
IHC was performed as described [8]. Briefly, slides were
rehydrated in xylene followed by graded concentrations of ethanol
and washed in PBS before heat-mediated antigen retrieval in
citrate buffer (pH 6, Life Technologies). Slides were cooled in
decreasing concentrations of warm citrate buffer in PBS followed
by incubation with Background Sniper (BioCare Medical,
Concord, CA) which was added to each slide for 15 min. Slides
were washed twice with PBS followed by incubation for 1 h with
blocking buffer (1% bovine serum albumin [BSA], 0.1% fish skin
gelatin, 0.1% Triton X-100, 0.05% Tween-20) with 2% goat
serum (Sigma, St. Louis, MO). After two washes with PBS,
primary antibody diluted in primary antibody buffer (1% BSA,
0.1% fish skin gelatin) was incubated with slides overnight in a
humidified chamber at 4uC. Primary antibodies used are listed in
Table S1 and included human leukocyte antigen-DR (HLA-DR,
clone LN3, Life Technologies) diluted 1:50, Surfactant Protein-B
(SP-B, polyclonal, Abcam, Cambridge, MA) diluted 1:1000,
Thyroid-specific transcription factor/NK2 homeobox 1 (TTF1,
clone 8G7G3/1, Abcam) diluted 1:1000, Vimentin (clone V6389,
Sigma) diluted 1:100, wide spectrum Cytokeratin (polyclonal,
Abcam) diluted 1:50, and Mouse IgG1 (Dako, Carpinteria, CA)
and rabbit IgG (Life Technologies) served as isotype controls.
Slides were washed twice with PBS for 5 min and incubated with
secondary antibody for 1 h in the dark at room temperature.
Secondary antibodies used were Alexa FluorH 488 goat anti-mouse
(Life Technologies) and Alexa FluorH 594 goat anti-rabbit (Life
Technologies) diluted 1:200 in fluorescence antibody diluent
(BioCare Medical). After washing twice with PBS, slides were
mounted with ProLong GoldH antifade reagent with 49,6-
diamidino-2-phenylindole (DAPI) (Life Technologies) and a
coverslip placed.
3,39-Diaminobenzidine (DAB) staining was performed for HLA-
E to assess MHC class I antigens in the decellularized scaffolds and
for SP-B and SP-C to further assess surfactant expression in the
recellularized kidney and lung scaffolds. Staining was performed
using Dako EnVision+System-HRP (DAB) kit (Dako) according to
the manufacturer’s instructions. Primary antibodies used were
HLA-E (clone MEM-E02, Thermo Fisher Scientific) diluted
1:100, SP-B diluted 1:1000, and SP-C (polyclonal, Abcam) diluted
1:500 in primary antibody buffer with 5% goat serum. Slides were
mounted with Cytoseal 60 mounting medium (Andwin Scientific,
Tryon, NC).
Quantitative RT-PCR for Kidney and Lung Genes
RT2 ProfilerTM PCR (Qiagen) array 96-well plates assessed
gene expression of 11 kidney-associated genes or 11 lung-
associated genes (Table S2 and Table S3, respectively). Total
DNA and RNA were extracted from cells preserved in Buffer RLT
at #-20uC and from scaffolds preserved in RNAlaterH solution at
#-80uC using the AllPrep DNA/RNA Mini kit (Qiagen) following
the manufacturer’s instructions. Scaffolds were processed in
multiple sections weighing ,30 mg each to ensure efficient
isolation of DNA and RNA.
cDNA was synthesized using the RT2 First Strand Kit (Qiagen)
according to the manufacturer’s instructions. The RT2 RNA QC
PCR array (Qiagen) was used to assess RNA quality prior to gene
expression analysis. Real-time PCR reactions (25 ml total volume)
were carried out in custom array plates with RT2 SYBRH Green
ROXTM qPCR Mastermix (Qiagen) following instructions pro-
vided by the manufacturer using a 7900H ABI Sequence Detection
System (Applied Biosystems, Foster City, CA). The PCR protocol
consisted of one cycle of 10 min at 95uC, followed by 40 cycles of
15 s at 95uC, and 1 min at 60uC. cDNA from three samples of
undifferentiated hESCs were used as the calibrator.
RNA expression was quantified according to the Comparative
CT method described in User Bulletin #2 (Applied Biosystems,
Foster City, CA; updated 2001) relative to the housekeeping gene
hypoxanthine phosphoribosyltransferase (HPRT) [9]. Positive and
negative controls (water) were included in each run. The results
were calculated as relative transcription or the n-fold difference
relative to a calibrator cDNA from three samples of undifferen-
tiated hESCs.
Figure 1. Sample collection. Immunohistochemistry (IHC), human
embryonic stem cells (hESC).
doi:10.1371/journal.pone.0064134.g001
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The number of cells seeded per scaffold was quantified by RT-
PCR analysis of e-globin after generation of a standard curve to
equate copy number with cell number [9]. qPCR reactions were
run in duplicate in 25 ml reaction volumes containing TaqMan
Universal PCR Master Mix (Applied Biosystems) with 400 nM of
forward and reverse primers and 100 nM probe. The PCR
protocol consisted of one cycle of 2 min at 50uC, 10 min at 95uC,
followed by 40 cycles at 15 s at 95uC, and 60 s at 60uC. Variations
in scaffold size were normalized by comparison of e-globin copy
number per mg of tissue.
Statistical Analysis
All data are shown as mean with the standard error of the mean
(SEM). Statistical analysis was performed using a two tailed
student’s t-Test with p # 0.05 considered statistically significant.
Results
Decellularized Kidney and Lung Scaffold Characterization
Our prior studies have shown intact cells are removed by the
decellularization process as determined by the absence of H&E
and DAPI staining of cell nuclei in decellularized kidney scaffolds
[7]. The quantity of residual DNA in the scaffolds compared to
fresh tissue was determined based on copies of the housekeeping
gene, e-globin, by qPCR. These studies indicated that 95.660.6%
of DNA was removed in decellularized scaffolds. Thus, although
the majority of DNA was removed by decellularization, scaffolds
did retain a small quantity of residual DNA.
Optimization of decellularization demonstrated that 1% SDS
for kidney and 0.1% SDS for lung yielded scaffolds with preserved
ECM structure while removing cells including MHC class I (HLA-
E) and II (HLA-DR) antigens as assessed by IHC (Figure 2).
Absence of DAPI and hematoxylin staining in the kidney and lung
scaffolds demonstrated cell nuclei were removed. Immunofluores-
cent staining for HLA-DR and DAB staining for HLA-E was
evident in the native kidney and lung and showed no staining in
decellularized kidney and lung scaffolds confirming removal of
both MHC antigens.
Comparison of Kidney and Lung Scaffold Composition
Proteomics analysis identified 439 proteins in the kidney scaffold
and 282 proteins in the lung scaffold (including known contam-
inants) with a false discovery rate of 0.2% for the kidney and 3.1%
for the lung. After removal of known contaminants, there were
220 proteins detected in the kidney scaffold that were not present
in the lung scaffold, 130 proteins expressed in the lung scaffold that
were not present in the kidney scaffold, and 110 proteins expressed
in both scaffolds. The top 100 most abundant proteins in each
scaffold were grouped according to function (Figure 3). The most
abundant ECM proteins found in the kidney were Annexin A2
(basement membrane; possible roles in heat-stress response,
calcium binding, angiogenesis), Fibrillin 1 (glycoprotein; fibrillin-
1-containing microfibrils provide long-term force bearing struc-
tural support), and Collagen alpha-1(IV) chain (glycoprotein; role
in cell adhesion, platelet-derived growth factor binding) [10]. The
most abundant ECM proteins found in the lung decellularized
scaffold were Periostin (secreted protein; role in cell adhesion and
heparan binding), Decorin (secreted protein; role in type I and II
Collagen, Fibronectin, and Transforming Growth Factor-b [TGF-
b, binding; matrix assembly]) [10], and Collagen alpha-1(IV).
Non-ECM proteins accounted for approximately 80% of the
proteins found in the kidney scaffold and approximately 50% of
the proteins found in the lung scaffold.
The scaffolds retained many proteins that have been viewed as
potentially beneficial [11] including a wide array of ECM proteins,
keratins, antimicrobial proteins such as Dermcidin and Defensin,
and growth factors including TGF-b, Epidermal Growth Factor-7
(EGF-7), and Heparin-binding Growth Factor-2 (Table S4). Also
noted were a number of proteins with the potential to induce an
adverse response by cells to the scaffold environment including the
presence of several complement components (CC6–CC9), stress
proteins (Heat shock cognate 71 kDa protein, Heat shock protein
b-1), and apoptosis-inducing proteins. Uromodulin (UMOD), a
renal tubule marker, was noted in very low quantity (represented
,0.03% total protein) in the kidney scaffold, and a lung
pneumocyte marker, von Willebrand factor (VWF), was noted in
low quantity (represented ,0.15% total protein) in the lung
scaffold. Neither HLA-E nor HLA-DR were detected. The
common housekeeping gene, Eukaryotic translation elongation
factor 1-alpha (EF1-a), was also present but not HPRT. Therefore,
HPRT was used for the internal control for gene expression.
Residual gene expression for kidney and lung-associated genes
was assessed in decellularized kidney and lung scaffolds; however,
the residual expression of the housekeeping gene, HPRT, was
extremely low (CT .39). These findings suggest that cellular
mRNA, including common housekeeping genes, were effectively
removed by the decellularization process and that residual gene
expression in decellularized scaffolds would not interfere with
qPCR results.
Comparison of Recellularization: Gene Expression
Undifferentiated hESCs were seeded onto juvenile decellular-
ized kidney or lung scaffolds. Gene expression of kidney or lung-
associated genes was assessed by qPCR. Compared to baseline
gene expression of undifferentiated hESCs (Day 0), expression
levels of tubule markers, Dipeptidase 1 renal (DPEP1) and
Heparan sulfate 6-O-sulfotransferase 1 (HS6T1), significantly
increased after 2 days of culture on kidney scaffolds and remained
elevated throughout the 8 days of culture. Other genes
upregulated by culture on kidney scaffolds on Day 8 included
fetal kidney tubule makers, Chloride Channel protein (CLCN7),
and Homeobox protein B6 (HOXB6), as well as two markers of
proximal tubules, Aminoacylase 1 (ACY1), and Fatty acid binding
protein 1 (FABP1) (Figure 4A). Although a trend of increased
expression of kidney genes on the lung scaffolds was observed, only
an increase in Intestinal alkaline phosphatase (ALPI), another
proximal tubule marker, was statistically significant compared to
Day 0. Taken together, these data confirmed a greater number of
kidney genes upregulated in cells cultured on kidney scaffolds than
on lung scaffolds.
Several lung-associated genes including Bactericidal/permeabil-
ity-increasing protein (BPI), which is expressed by respiratory
epithelial cells of the bronchus and nasopharynx, SP-B, SP-C, and
VWF, which are expressed by pneumocytes, were transiently
elevated in kidney scaffolds by Day 2 but returned to baseline by
Day 8 (Figure 4B). Similarly, BPI, Mucin 5B (MUC5B), another
marker of respiratory epithelial cells, and SP-B were upregulated
on the lung scaffolds after 2 days in culture but by 8 days only
VWF demonstrated increased gene expression compared to Day
0. Based on these data, pneumocyte and respiratory epithelial
genes were transiently upregulated after initial introduction of cells
to both the kidney and lung scaffolds but statistical significance was
not apparent after further culture.
Expression of kidney genes, UMOD (Tamm-Horsfall glycopro-
tein) and Solute carrier family 12 (SLC12A), as well as the lung
genes, Clara Cell specific protein (Uteroglobin, SCGB1A1) and
TTF1/NK2 homeobox 1 (TTF1/NKX2.1), were not detected in
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cells cultured on either kidney or lung scaffolds. Compared to Day
0 undifferentiated hESCs, the cells cultured on kidney and lung
scaffolds showed significant differences in tissue-specific gene
expression over time, indicating that the scaffold was able to
partially stimulate differentiation of hESCs to express tissue-
specific markers. However, when gene expression levels of the
differentiating cells on kidney versus lung scaffolds were compared
on the same day, no statistically significant differences were found.
These findings suggest that the gene expression response of hESCs
to the scaffold ECM is similar for kidney and lung scaffolds despite
statistical significance when compared to undifferentiated hESCs.
Hence, the scaffolds were able to drive differentiation of hESCs to
express kidney and lung genes, but no statistically significant
difference in the gene expression patterns between hESCs seeded
on kidney versus lung scaffolds were detected.
Comparison of Recellularization: Morphology
Cells in the kidney scaffold formed thick symmetrical epithelial
(Cytokeratin+) tubules, whereas cells in the lung scaffolds lined the
alveolar spaces and formed thin networks of surfactant protein
expressing cells (Figure 5). Despite different morphology and
spatial organization, cells in both scaffolds expressed Cytokeratin,
SP-B, and SP-C.
To determine if the observed expression of surfactant proteins
was confounded by residual staining of proteins remaining in the
decellularized scaffold or was due to a response to a non-specific
3D ECM environment, IHC was performed on kidney and lung
decellularized scaffolds (non-seeded) and hESCs cultured in
MatrigelTM, respectively. IHC performed on decellularized
scaffolds prior to as well as following incubation with medium
did not stain for surfactant proteins (Figure 6A). These findings
suggest that surfactant protein is not residually expressed in the
scaffold nor acquired by the scaffold after culture. Cells in the
MatrigelTM controls did not express SP-B but weakly expressed
SP-C, suggesting a minor degree of non-specific differentiation of
hESCs in response to a non-tissue-specific ECM-rich environ-
ment.
To examine the possible contribution of residual soluble
molecules in the decellularized scaffolds on the stimulation of
surfactant protein expression, embryoid bodies were exposed to
various concentrations of SDS in culture medium or the
supernatant from non-seeded decellularized scaffolds incubated
in medium. Surfactant protein expression in embryoid bodies was
not affected by the addition of SDS to the medium (Figure 6B).
Staining of cells cultured in 0.00001%, 0.0001%, or 0.001% SDS
appeared similar to control with 0% SDS (medium alone). Cells
cultured in medium with SDS concentrations of 0.01% or greater
displayed membrane lysis and could not be collected at the end of
the 8-day culture period. In addition, control embryoid bodies
were Vimentin+ (mesoderm and parietal endoderm) and did not
express Cytokeratin, SP-B, or SP-C. Interestingly, culture of
embryoid bodies with supernatants from empty scaffolds induced
mild diffuse surfactant protein expression (Figure 6C). These
findings suggest that soluble molecules released from cultured
scaffolds may partially be responsible for stimulating surfactant
expression, likely in a dose-dependent manner and dictated by the
amount of the molecules remaining in the original decellularized
scaffold.
Discussion and Conclusions
Decellularized tissue scaffolds provide a platform for developing
functional tissue replacements by offering mechanical, structural,
and biological properties similar to the native tissues from which
they were derived. The first goal of the current study was to
characterize the residual contents of kidney and lung scaffolds
including DNA/RNA, MHC antigens, cellular markers, growth
factors, and proteins to better understand and utilize the scaffolds
for translational therapies. Kidney and lung were selected for a
comparative evaluation because of their similar pattern of
organogenesis, which is driven by reciprocal mesenchymal-to-
epithelial interactions that lead to branching morphogenesis.
Development of the kidney and lung depends on many of the same
cytokines such as retinoids and bone morphogenic proteins [12].
These two organs are highly vascularized and have complex
branching networks of specialized cells. Moreover, differences in
developmental transcription factors enabled evaluation of tissue-
specific expression of genes that are not shared between the kidney
and lung during development. In addition, physical differences in
composition may aid in determining how the kidney versus lung
must be decellularized, and the approaches necessary for effective
recellularization.
It has been suggested that decellularized scaffolds retain
cytokines that are beneficial for scaffold recellularization and host
integration. Decellularized tracheal and brain matrices maintain
expression of basic fibroblast growth factor-2 (FGF-2) and TGF-b,
respectively. The presence of residual cytokines in decellularized
matrices was sufficient to provide pro-angiogenic properties using
the chicken embryo chorioallantoic membrane [13–15]. Similar to
studies with tracheal and brain matrices, and through proteomics
analysis, the current study revealed the presence of several residual
growth factors in the kidney and lung scaffolds that may be
beneficial in scaffold recellularization. Insulin-like growth factor
binding protein-7, which plays a role in cellular proliferation and
vessel stabilization [16], was detected in the kidney scaffold. In
addition, both kidney and lung scaffolds contained EGF-7
precursor, which plays a role in vascular tubulogenesis and
protects endothelial cells from hypoxia-induced apoptosis [17].
EGF-7 has also been implicated in kidney development and shown
Figure 2. Decellularization of rhesus monkey kidney and lung sections. Decellularization of kidney transverse sections with 1% SDS (A–C)
over 10 days and IHC for MHC class I (HLA-E) and MHC class II (HLA-DR) markers in the native and decellularized kidney scaffold (D–I).
Decellularization of sagittal caudal lung lobe sections with 0.1% SDS (J–L) over 10 days and IHC of HLA-E and HLA-DR markers in the native and
decellularized lung scaffold (M–R). 49,6-diamidino-2-phenylindole (DAPI) for cell nuclei.
doi:10.1371/journal.pone.0064134.g002
Figure 3. Protein composition of kidney and lung scaffolds.
Compositional breakdown of proteins found in kidney and lung.
doi:10.1371/journal.pone.0064134.g003
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to enable transformation of mesenchymal cells to stromal
(interstitial) cells [18]. Another factor present in both kidney and
lung scaffolds was TGF-b, which has been shown with FGF-2 to
induce nephrogenesis through a Wnt-dependent pathway and
develop the polarized tubular epithelia of the nephron [19,20].
Heparin-binding growth factor-2/FGF-2 was detected in the lung
scaffold and is one of the most potent mitogens in stimulating lung
epithelial cell proliferation and is an inducer of surfactant protein
genes [21]. The presence of these growth factors may be sufficient
to potentiate cell infiltration and differentiation within the scaffold.
Additional studies will be needed to assess the contribution of each
growth factor to recellularization and determine whether the
quantity present after decellularization is sufficient to induce a
cellular response.
In addition, decellularized tissues were shown to retain
antimicrobial proteins that may be beneficial for in vitro culture
as well as downstream host integration. Potent antimicrobial and
anti-fungal proteins such as Dermcidin-like protein found in
kidney and lung scaffolds, and Defensin found in the lung, are
consistent with findings by others who have demonstrated
bacterial resistance of ECM-derived bladder and liver scaffolds
[22].
These studies also highlight the importance of addressing the
question of whether certain scaffold components and residual
proteins may retain elements that could result in rejection post-
transplantation. PCR revealed 96% DNA removal thus a small
quantity of DNA remained emphasizing that additional steps such
as enzymatic digestion, more vigorous mechanical agitation, or
additional washes that affect pH or dielectric constants may be
necessary to further enhance removal of residual DNA without
damaging the ECM. Undigested DNA from dead cells and
endogenous mitochondrial ’damage’-associated molecular patterns
resulting from cellular trauma can cause activation of the innate
immune response and elicit neutrophil-mediated organ injury
creating a sepsis-like state [23,24]. Beneficial as well as concerning
outcomes have been reported for macrophage activation in
response to abdominal wall implantation of decellularized dermal
or bladder tissues [25–27]. Thus, the potential consequences of
residual cellular materials remains a concern.
Although proteomics analysis was performed on one kidney and
one lung sample, additional samples would likely still reveal that
ECM proteins only make up part of the several hundred proteins
that remain in decellularized scaffolds. These findings suggest that
in studies that utilize decellularized tissues, the cells are interacting
Figure 4. Gene expression of recellularized kidney and lung scaffolds. Timeline indicates timing of sample collection. Gene expression of
kidney-associated genes: Aminoacylase 1 (ACY1), Intestinal alkaline phosphatase (ALPI), Cadherin-16 (CDH16), Chloride Channel protein (CLCN7),
Dipeptidase 1 renal (DPEP1), Fatty acid binding protein 1 (FABP1), Homeobox protein B6 (HOXB6), Heparan sulfate 6-O-sulfotransferase 1 (HS6T1),
and Solute carrier family 9 member 3 (SLC9A3) (A), and lung-associated genes: Bactericidal/permeability-increasing protein (BPI), Dystroglycan 1
(DAG1), Forkhead box A2 (FOXA2), Lysosomal-associated membrane protein 3 (LAMP3), Lymphocyte cytosolic protein 2 (LCP2), Mucin 5B (MUC5B),
Surfactant protein-B (SP-B), SP-C, and Von Willebrand factor (VWF) (B) in the recellularized kidney and lung scaffolds after 2 and 8 days in culture 6
SEM. Statistically significant differences in expression compared to undifferentiated hESCs from Day 0 are indicated by asterisks (*p # 0.05).
doi:10.1371/journal.pone.0064134.g004
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with and responding to more than just the ECM. It is likely that
the combination of ECM proteins with residual growth factors and
other soluble molecules that remain in the decellularized scaffolds
are responsible for directing differentiation and organization of the
cells. This may be useful in cases of successful recellularization;
however, these residual proteins may also be the cause of
challenges encountered with consistent recellularization through-
out the scaffold. It is not known if the successful use of
decellularized tissues is only due to the structural benefits of the
ECM proteins or if it is the combinatorial effects of ECM with an
array of residual growth factors and molecules. However,
preservation of these additional factors may also mean retention
of other detrimental proteins that will present challenges for
translation. Future studies will be needed to evaluate the potential
consequences of the residual non-ECM proteins in an in vivo
environment, as well as additional decellularization strategies to
enhance the removal of potentially immunogenic materials
including more rigorous washing strategies to improve protein
antigen removal [28].
Several studies have suggested that residual SDS may prevent
cell infiltration due to cytotoxicity. The protonated form of an
amino group on lysine, which is displayed on ECM proteins, forms
a strong bond to the negatively charged SDS [29,30]. This study
exposed embryoid bodies to a wide range of concentrations of SDS
in medium; $0.01% was shown to result in complete lysis of cells.
Thus, assumptions can be made that the concentration of residual
SDS in decellularized scaffolds is well below 0.01% since lysis was
not observed in cells grown within the scaffolds.
A promising finding from this study is the ability of the scaffolds
to physically shape tissue-appropriate structures. hESCs formed
tubules in kidney scaffolds and the same hESC population
differentiated into surfactant protein-secreting cells that organized
around alveolar spaces in the lung scaffolds. The ECM
composition and presentation of membrane-bound and soluble
proteins differs for a renal tubule when compared to an alveolus;
therefore, it is expected that different contact-dependent pathways
may be stimulated in hESCs upon adhesion to different scaffolds
that promote tissue-specific differentiation. Cells in both scaffolds
expressed Cytokeratin, SP-B, and SP-C. Although additional
analysis would need to be performed to clearly identify and
characterize the differentiated cells within the scaffolds, Cytoker-
atin typically stains epithelial cells of the respiratory tract,
including basal, ciliated, goblet, and alveolar cells [31]. In the
native kidney, Cytokeratin stains the epithelial cells of the Loop of
Henle and collecting ducts [32]. SP-B is expressed by pneumocytes
in the native lung whereas SP-C is expressed by pneumocytes as
Figure 5. IHC of decellularized kidney and lung scaffolds recellularized with undifferentiated hESCs. Staining is shown in the native
kidney (A–D) and recellularized kidney scaffold (E–H, 10X; I–L, 40X), native lung (M–P), and recellularized lung scaffold (Q–T, 10X; U–X, 40X).
Staining was performed for Cytokeratin and Vimentin (A, E, I,M, Q, U), SP-B and Thyroid-specific transcription factor/NK2 homeobox 1 (TTF1) (B, F, J,
N, R, V), SP-B with DAB (C, G, K, O, S, W), or SP-C with DAB (D, H, L, P, T, X). The white or black box in the 10X image highlights the region
magnified in the higher magnification 40X image directly below; glomeruli (g), tubules (t), alveolus (a). DAPI = cell nuclei.
doi:10.1371/journal.pone.0064134.g005
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well as macrophages in the lung; weak staining has been noted in
some kidney tubules [33].
To further characterize the differentiation state of the cells in
each tissue scaffold, a panel of genes highly expressed in either
kidney or lung was examined by qPCR. Here, results revealed that
hESCs seeded onto decellularized kidney scaffolds acquired a
significant increase in the expression of six kidney-associated
markers whereas hESCs seeded onto lung scaffolds only acquired
expression of one kidney-associated marker (ALPI). In contrast,
short-term expression of lung-associated genes was observed
regardless of the tissue scaffold on which undifferentiated hESCs
were cultured. When examined in a longitudinal manner that
followed gene expression of the cells over the entire culture period
(8 days), statistically significant changes in tissue-specific gene
expression were noted for cells on both scaffolds collected on Day
8 compared to the Day 0 undifferentiated hESC starting
population. However, cross-comparison of a given gene for cells
in kidney or lung scaffolds at a single time point demonstrated no
statistical significance between the two scaffolds. These findings
suggest that the scaffolds influence hESC differentiation but do not
have the capability of genotypic lineage specification based solely
on gene response. Alternative culture conditions may be required
to induce appropriate and sustained tissue-specific gene expres-
sion. Because of their mechanistic similarities during ontogeny, the
window of time included for the current study (8 days) may have
limited the ability to fully capture divergence in gene expression of
hESCs in kidney and lung scaffolds.
To investigate the expression of surfactant proteins by cells in
the recellularized kidneys, embryoid bodies were cultured in a
range of SDS concentrations to assess the potential contribution of
residual SDS on inducing expression of these proteins by cells.
Although no correlation was found between increasing concen-
trations of SDS and surfactant protein expression, diffuse
surfactant expression was noted for cells exposed to the culture
supernatants of non-seeded decellularized kidney scaffolds. This
finding suggests that a soluble factor in the empty decellularized
scaffold is released into the medium during the culture period and
is responsible for stimulating mild surfactant protein expression by
embryoid bodies and likely the hESCs in the kidney and lung
scaffolds as well. Additional proteomics analysis could be used to
identify all soluble proteins that are released from the empty
decellularized scaffolds while in culture. It is likely that one or
more of these soluble molecules were responsible for the observed
surfactant protein expression.
In summary, this study highlights the potential use of
decellularized tissues as a potent spatial mitogen and provides
new insights into tissue-specific properties that can be exploited to
drive cells from a pluripotent state to formation of tissue-specific
structures without the addition of exogenous growth factors.
Proteomics analysis of kidney and lung decellularized scaffolds also
showed the inevitable translational hurdles in the form of
hundreds of non-ECM residual proteins contained within
scaffolds. Overall, these findings have demonstrated the ability of
scaffold ECM to guide the spatial organization of cells into tissue-
specific structures, although additional approaches will be needed
to ensure consistent and efficient recellularization throughout the
scaffold.
Supporting Information
Table S1 Antibodies for Immunohistochemistry
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Figure 6. SP-B staining of decellularized scaffolds and embryoid bodies. IHC for SP-B on decellularized kidney and lung scaffolds before
culture and after 8 days of culture in medium (A). Fresh kidney and lung stained for SP-B were included for negative and positive controls; glomeruli
(g), tubules (t), alveolus (a). SP-B staining of embryoid bodies cultured for 8 days in 0% (Control) and 0.001% SDS in medium (B). SP-B staining of
embryoid bodies cultured for 8 days in supernatant from incubated decellularized kidney scaffolds (C).
doi:10.1371/journal.pone.0064134.g006
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